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Abstract
Background: Most blunt aortic injuries occur in the proximal proximal descending aorta causing acute transection
of this vessel. Generally, surgical repair of the ruptured segment of aorta is associated with high rates of morbidity
and mortality and in this view endovascular treatment seems to be a valid and safer alternative. Aim of this article
is to review our experience with endovascular approach for the treatment of acute traumatic rupture of descending
thoracic aorta.
Methods: From April 2002 to November 2014, 11 patients (9 males and 2 females) were referred to our Department
with a diagnosis of acute transection of thoracic aorta. Following preoperative Computed Tomography (CT) evaluation,
thoracic endovascular aortic repair (TEVAR) with left subclavian artery coverage was performed. Follow-up consisted
clinical and instrumental (CT, Duplex ultrasound) controls at discharge, 1, 3 and 6 months and yearly thereafter.
Results: At 12-year follow up, the overall survival for the entire patients cohort was 100 %, no major or minor
neurological complications and no episode of left arm claudication occurred. Cardiovascular, respiratory and bleeding
complications, in the early period, was represented by minor, non fatal events. No stent graft failure, collapse, leak or
distal migration were detected at CT scan during the entire follow up period.
Conclusions: According to our experience, despite the small number of patient population, TEVAR procedure with
with left subclavian artery coverage, performed in emergency settings, seems to provide excellent long term results.
Trials registration: The protocol was registered at a public trials registry, www.clinicaltrials.gov (trial identifier
NCT02376998).
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Background
Blunt aortic injury is second only to head injury as the
leading cause of death from vehicle crashes as a conse-
quence of deceleration trauma [1–3]. The aortic tear
occurs most often at the aortic isthmus, and, in order of
frequency, affects the proximal descending aorta, the
ascending aorta, the aortic arch, distal descending aorta,
and the abdominal aorta [4–6]. This trauma generally
progresses into a free rupture of the aorta and causes
immediate death at the site of the accident in the 75 %
to 80 % of the cases; only 10 % to 15 % of injured people
reach a hospital alive [7, 8]. These few patients, in 90 %
of cases, have a transection of the thoracic aorta at the
isthmus level with a contained rupture [9, 10]. Moreover,
these patients often have several other injuries (head
trauma, multiple bone fractures, visceral lesions) and for
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this reason, the immediate treatment of aortic transec-
tion can be imperative in decreasing blood loss to pre-
vent continuous fatal bleeding [9]. Several studies have
shown that surgical repair of an aortic rupture is associ-
ated with high rates of morbidity and mortality, particu-
larly in patients with multiple injuries [11, 12] and it had
been delayed, because of coexisting injuries, which ren-
dered the surgical is unacceptably high: severe head
trauma, serious skeletal fractures, extensive burns, severe
respiratory insufficiency, and sepsis [13–16]. However,
the possible benefits of this management strategy are ne-
gated when one considers that 2 % to 5 % of these pa-
tients develop secondary rupture, mostly within one
week of the initial injury [17]. Initially developed for the
elective repair of degenerative aneurysms, thoracic endo-
vascular aortic repair (TEVAR) has become the treatment
of choice for all conditions, both elective and emergent,
involving the descending thoracic aorta [17, 18]. The re-
sult has been a decrease in both operative mortality and
morbidity for patients with these conditions and it has of-
fered a less invasive and safer alternative to open surgery
in acute, high-risk surgical patients [17–19].
The aim of this study is to describe our experience
with the endovascular treatment of patients having acute
traumatic rupture of the descending thoracic aorta.
Methods
From April 2002 to November 2014, 11 patients (9 male
and 2 female patients) were referred to our department
with a diagnosis of acute transection of thoracic aorta.
Acute rupture was defined as disruption of the aortic
wall with blood flow precariously maintained within the
vascular lumen by the adventitia and mediastinal sur-
rounding tissues only (contained rupture) [20]. Signs
of impending rupture were considered: discontinuity
of aortic contour, contrast media extravasation, rapid
growth rate of pseudoaneurysm, periaortic hematoma,
and/or hemorrhagic pleural effusion.
This study was approved by the Investigational Review
Board, in accordance with the Declaration of Helsinki
andthe Guideline for Good Clinical Practice. Before the
beginning of the study, all participants provided written
informed consent. The protocol was properly registered
at a public trials registry, www.clinicaltrial.gov (trial
identifier NCT02376998).
Tevar procedure
As described previously [21], pre-operative evaluation
was done by Computed Tomography (CT) considering
the following criteria:
1. site of proximal or distal endograft deployment
according to the aortic map proposed by Ishimaru
[22] and applied by others [23];
2. a minimum length of 15 mm from the aortic lesion,
or from the entry site in dissections, to the left
subclavian artery and to the coeliac trunk;
3. maximum aortic landing zone diameter of 40 mm;
4. absence of circumferential thrombus or atheroma
within the landing zone;
5. absence of significantly tortuous and inadequate
access vessels.
According with recent evidences [24, 25], in all cases
with a proximal lesion near the origin of the left sub-
clavian artery determining its intentional covering by the
stent-graft in order to increase the proximal landing
zone, revascularization by supra-aortic transpositions
was not considered; patency of both vertebral arteries
were documented before the procedure by duplex
ultrasonography.
A cerebrospinal fluid catheter (CSF) was inserted be-
fore the operation at the level of L3 or L4 to detect
neurologic events as spinal cord ischemia due to sus-
tained hypotension during stent-graft placement or to
coverage of major medullary arteries, and a pressure of
10 mm Hg or below was maintained. This pressure was
monitored for 48 h after the operation in the absence of
lower extremity deficits. The mean arterial pressure was
kept between 90 and 120 mmHg for the first 72 h to
prevent spinal cord hypoperfusion [21].
The Talent™ and, after having been modified, the
Valiant™ endoluminal stent-graft systems (Medtronic
Inc., Santa Rosa, CA, USA) were used in all patients
with its deployment maintaining a systolic pressure at
80 mmHg. The diameter of the stent graft was calcu-
lated from the largest diameter of the proximal/distal
neck with an oversizing factor of 10-20 %. The proce-
dures were done with local or general anaesthesia in case
of unstable pre-operative hemodynamic conditions. Dur-
ing general anesthesia, patients received mechanical ven-
tilation. Blood pressure was monitored by means of right
radial artery cannulation. Ceftriaxone (2 g administered
intravenously) was administered before the procedure.
Depending on the risk of bleeding, a maximum dose of
5000 UI of heparin was administered.
After the procedure was completed, a digital subtrac-
tion angiography and echocardiography with color-flow
mapping were performed to verify the correct position-
ing of the stent and to detect any primary endoleak.
Technical success of TEVAR was considered the place-
ment of patent endograft, exclusion of the false lumen in
case of Type B aortic dissection (TBAD) and absence of
type I or III endoleaks. Endoleaks were defined accord-
ing to the Committee for Standardized Reporting
Practices in Vascular Surgery of The Society for Vascular
Surgery/American Association for Vascular Surgery [26].
Type I endoleak was defined as proximal or distal
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attachment site leak and type III endoleak was consid-
ered as junctional leak between stent grafts if more than
one graft was used.
Routine examination of heart, lung, liver, and kidney
function and contrast-enhanced computed tomographic
(CT) scanning or angiographic analysis were conducted
in all hemodynamically stable patients. Hemodynamically
compromised patients underwent CT analysis, trans-
esophageal echocardiographic (TEE) analysis, or both just
before emergency endovascular repair.
Follow up
Follow-up consisted of CT scan before hospital dis-
charge, at 1, 3 and 6 months, and yearly thereafter. Data
from early mortality and postoperative complications as
paraplegia or paraparesis, renal and respiratory failure,
myocardial infarction, ventricular arrhythmias, con-
gestive heart failure were also collected. We defined
paraplegia or paraparesis partial (−paresis) or complete
(−plegia) loss of voluntary motor function in the pelvic
limbs [27], acute renal failure as acute deterioration of
kidney function reflected by a significant increase in
serum creatinine [28], respiratory failure as the im-
paired ability of the respiratory system to maintain ad-
equate oxygen and carbon dioxide homeostasis [29],
myocardial infarction as an imbalance between myo-
cardial oxygen supply and demand [30], ventricular ar-
rhythmias (VA) as the presence of ventricular premature
beats, ventricular tachycardia (VT), ventricular flutter,
torsades de pointes (TdP), accelerated idioventricular
rhythm, or ventricular fibrillation (VF) [31, 32], and
congestive heart failure when the heart is unable to
maintain an adequate circulation of blood in the bod-
ily tissues or to pump out the venous blood returned
to it by the veins [33].
To evaluate left arm function a complete clinical and
instrumental (duplex ultrasound) evaluation of the left
arm was performed in all patients immediately after the
procedure and 12, 24, and 72 h later and then at 3,6 and
12 months postoperatively and yearly thereafter, as pre-
viously reported [25].
Statistical analysis
SPSS 21.0 software (IBM) was used for statistical ana-
lysis. We defined this study as exploratory; therefore, we
did not determine a power calculation. In this light,
these results could only be labeled as exploratory.
Results and discussion
An early emergency endovascular procedure were per-
formed in all patients with a median time from
trauma of 3 h (range, 1–10 h). The mean age was
36.9 ± 10.3 years (range, 18–53 years) (Tables 1 and 2).
Stent procedures were performed by a multidisciplinary
team of cardiovascular surgeons, interventional cardiolo-
gists and anesthesiologists and technical success was ob-
tained in all patients submitted to stent graft repair
(100 %).
Early outcomes
The early mortality defined as either in-hospital or
within 30 days was 0/11 (0 %) (Table 3).
After surgical intervention, all patients were admit-
ted to the intensive care unit, where mean stay was
47 ± 15 h. The mean hospital stay was 11 ± 8 days;
during this time, no transient or permanent neuro-
logic deficits were reported. No cases of paraplegia/
paraparesis, renal failure, cerebrovascular accident,
myocardial infarction, ventricular arrhythmias, con-
gestive heart failure were observed. No supra-aortic
revascularization as subclavian- to - carotid bypass
intervention was performed because no pre-operative
hemodinamic alterations of vertebral arteries were re-
vealed by duplex ultrasonography without any case of
post-operative cerebrovascular accident.
Two cases of respiratory failure which required pro-
longed intubation, 1 case of pleural bleeding, 1 case of
vascular access complication due to wound dehiscence
for infection, 3 cases of Atrial Fibrillation were observed.
A postimplantation syndrome, consisting of leukocytosis
and fever, was observed in all patients.
Long-term outcomes
Overall survival for the entire cohort was 100 %. At
12-year follow-up with a 11 years period of median
follow up, all the patients were still alive. None of
them required open surgical conversion, or secondary
endovascular procedures during follow-up. At CT
Table 1 Baseline of treated patients
Characteristics
Age, y
Mean ± SD 36.9 ± 10.3
Median (range) 18-53
Male 9 (81.81 %)
Female 2 (18.18 %)
Hypertension 1
Chronic obstructive pulmonary disease (COPD) 1
Gastrointestinal conditions 0
Paraplegia 0
Congestive heart failure 0
Diabetes 1
Stroke 0
Renal insufficiency 0
Myocardial infarction 1
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scan, no stent-graft failure or collapse, leak, or distal
migration was detected in any of the 11 survivors.
No episode of left arm claudication (clinical or instru-
mental) was reported along the entire follow up period
(Table 3).
Traditional treatment of blunt aortic injury has been
early open surgical repair with graft interposition, with
or without adjuncts to maintain distal perfusion. How-
ever, open repair carries a 2.9 to 7 % risk of paraplegia
and an operative mortality rate ranging from 15 to
23.5 % [34, 35]. Moreover, these patients typically have
other severe injuries, and the use of extracorporeal cir-
culation, particularly the use of systemic heparinization,
complicates the management of those associated injuries
[36]. The introduction of an endoluminal approach rep-
resents a significant advance in the care of patients with
thoracic aortic transections. Although endovascular
management of aortic rupture was initially restricted to
high-risk patients with multiple injuries, in many centers
it has now become the preferred first treatment even in
young or low-risk patients [37, 38]. The benefits of
TEVAR include no need for thoracotomy or single lung
ventilation, decreased use of systemic anticoagulation,
avoidance of aortic cross-clamping, less blood loss, less
postoperative pain and lower paraplegia rate and evi-
dences have shown a 7.2 % mortality rate for endovascu-
lar repair versus 23.5 % for open repair.
It is known that people who suffer this type of injury
and who are treated with TEVAR are young: for this
reason, several studies have shown that long-term
follow-up data are clearly critical to assess the durability
of TEVAR in younger population of patients, who have
longer life expectancies than patients with aneurysmal
disease. Material failures, such as stent fractures and fab-
ric fatigue, may become more significant during ensuing
decades of follow-up. Because the aorta tends to dilate
with age, smaller-sized devices appropriate at the time of
implantation may lose their fixation over time [39].
Thus, evaluation of long-term device performance in
this disease-specific condition is also of high importance.
As previously described [39], a 10-year follow-up period
in TEVAR patients demonstrated that the reduction in
the operative mortality rate of TEVAR, compared with
open repair, lasts over time, without any device-related
issues. The endoleaks are more frequent in patients with
aneurysmal diseases treated with endovascular proce-
dures than patients with aortic transaction: as showed
[39], these findings corroborate the observation that aor-
tic expansion seems to be more related to the natural
history of the thoracic aorta than to any effect of the
stent-graft.
Table 2 Injury characteristics
Characteristic
Mechanism of blunt aortic injury
Vehicle accidents 9 (81.81 %)
Pedestrian hit by motor vehicles 1 (9.09 %)
Fall 1 (9.09 %)
Extent of aortic injury
Grade I: intimal tear 0 (0 %)
Grade II: intramural hematoma 1 (9.09 %)
Grade III: aortic pseudoaneurysm 9 (81.81 %)
Grade IV: free rupture 1 (9.09 %)
Location of aortic injury
Isthmus (just distal to the left subclavian artery
to the third intercostals artery)
11 (100 %)
Distal descending thoracic aorta 0 (0 %)
Associated traumatic injuries
Lung injury (pneumothorax) 3 (27.27 %)
Unstable fracture cervical spine 1 (9.09 %)
Rib fracture 11 (100 %)
Sternum fracture 2 (18.18 %)
Related injury (solid organ, bowel, bladder,
or diaphragm injury)
Pleural effusion 7 (63.63 %)
Testicle fracture 1 (9.09 %)
Spleen fracture 4 (36.36 %)
Contained rupture of bowel 1 (9.09 %)
Apache –II score
11-15 2 (18.18 %)
16-20 3 (27.27 %)
26-30 4 (36.36 %)
>30 2 (18.18 %)
Table 3 Early and long term complications
Complication Early complications Long term
complications
No of patients 11
Paraplegia/paraparesis 0 (0) -
Renal failure 0 (0) -
Respiratory failure 2 (18.2 %) -
Cardiac arrhythmias -
Atrial Fibrillation 3 (27.27 %)
Cerebrovascular accident 0 (0) -
Bleeding/Pleural effusion 1 (9.1 %) -
Reintervention 0 (0) -
Vascular access-related
complications
-
Wound dehiscence for infection 1 (9.1 %)
Left Arm Claudication
(clinical or instrumental)
0 (0) -
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In our study, with a median follow up of 11 years,
among the early complications there was no mortality or
major neurological complications and no paraplegia/
paraparesis events. No patients developed left arm clau-
dication. Cardiovascular, Respiratory and bleeding com-
plications, in the early period, was represented by minor,
non-fatal events.
There were no long term complications and the tech-
nical success rate was 100 % in all procedures.
The main limitation of this study is the small volume
of patients which prevent to make solid conclusion. Fur-
thermore, this study was based upon a non-randomized
single center experience.
Conclusions
According to our experience, and considering also the
aforementioned limitiations, we can assume that TEVAR
with left subclavian artery coverage for the treatment of
acute traumatic rupture of the descending thoracic
aorta, can be accomplished safely in emergency settings
with minimal morbidity and excellent long term results.
Nevertheless, further studies with a wider population of
patients are required to confirm our results.
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